Last $5.85 USD
Change Today +0.19 / 3.36%
Volume 547.7K
ARRY On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin Koch Ph.D.

Co-Founder, President and Chief Scientific Officer, Array BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

52$845,950
As of Fiscal Year 2012

Background*

Dr. Kevin Koch, Ph.D. is a Co-Founder of Array Biopharma, Inc. and has been its President and Chief Scientific Officer since May 1998. Prior to in Array, Dr. Koch served as Associate Director of Medicinal Chemistry and Project Leader for the Protease Inhibitor and New Leads project teams from May 1995 to April 1998 for Amgen Inc. From September 1988 until May 1995, Dr. Koch held various positions with Pfizer Central Research, including Senior Research Investigator-Project ...

Read Full Background

Corporate Headquarters*

3200 Walnut Street
Boulder, Colorado 80301

United States

Phone: 303-381-6600
Fax: 303-449-5376

Board Members Memberships*

1998-2012
Co-Founder, President and Chief Scientific Officer

Education*

BS
State University of New York
PhD
University of Rochester

Other Affiliations*

Annual Compensation*

Salary$442,500
Total Annual Compensation$442,500

Stock Options*

Restricted Stock Awards$131,540
All Other Compensation$27,700
Exercisable Options539,632
Exercisable Options Value$60,938
Unexercisable Options202,500
Unexercisable Options Value$65,363
Total Value of Options$126,300
Total Number of Options742,132

Total Compensation*

Total Annual Cash Compensation$529,298
Total Short Term Compensation$442,500
Other Long Term Compensation$159,240
Total Calculated Compensation$845,950
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARRY:US $5.85 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$488.8K
Daniel R. Passeri MSc., J.D.Chief Executive Officer and Director
Curis, Inc.
$601.9K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
James S. J. Manuso Ph.D., MBAChairman of The Board and Chief Executive Officer
Astex Pharmaceuticals, Inc.
$1.3M
Werner Lanthaler MBA/MPAChief Executive Officer
Evotec AG
€714.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAY BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.